Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
2.500
-0.370 (-12.89%)
Nov 21, 2024, 2:41 PM EST - Market open
Intensity Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 6.4 | 3.53 | 2.42 | 2.16 | 1.17 | 1.24 |
| Research & Development | 10.33 | 4.79 | 5.13 | 5.86 | 5.05 | 4.44 |
| Operating Expenses | 16.73 | 8.32 | 7.55 | 8.01 | 6.22 | 5.68 |
| Operating Income | -16.73 | -8.32 | -7.55 | -8.01 | -6.22 | -5.68 |
| Interest Expense | -0 | -0.31 | -0.08 | - | - | - |
| Interest & Investment Income | 0.46 | 0.32 | 0 | 0 | 0.07 | 0.15 |
| Other Non Operating Income (Expenses) | 0.01 | 0.02 | 0.05 | 0.12 | 0.12 | 0.14 |
| EBT Excluding Unusual Items | -16.26 | -8.28 | -7.58 | -7.9 | -6.03 | -5.38 |
| Other Unusual Items | - | -2.26 | - | - | - | - |
| Pretax Income | -16.26 | -10.54 | -7.58 | -7.9 | -6.03 | -5.38 |
| Net Income | -16.26 | -10.54 | -7.58 | -7.9 | -6.03 | -5.38 |
| Preferred Dividends & Other Adjustments | - | 1.32 | - | - | - | - |
| Net Income to Common | -16.26 | -11.86 | -7.58 | -7.9 | -6.03 | -5.38 |
| Shares Outstanding (Basic) | 14 | 9 | 3 | 3 | 3 | 3 |
| Shares Outstanding (Diluted) | 14 | 9 | 3 | 3 | 3 | 3 |
| Shares Change (YoY) | 129.62% | 152.67% | - | 0.02% | 0.19% | - |
| EPS (Basic) | -1.18 | -1.38 | -2.22 | -2.32 | -1.77 | -1.58 |
| EPS (Diluted) | -1.18 | -1.38 | -2.22 | -2.32 | -1.77 | -1.58 |
| Free Cash Flow | -13.5 | -7.21 | -5.48 | -6.83 | -5.37 | -4.42 |
| Free Cash Flow Per Share | -0.98 | -0.84 | -1.61 | -2.00 | -1.58 | -1.30 |
| EBIT | -16.73 | -8.32 | -7.55 | -8.01 | -6.22 | -5.68 |
Source: S&P Capital IQ. Standard template.
Financial Sources.